A Study of FB2001 for Inhalation in Healthy Chinese Adults

Summary

FB2001 is a novel inhalable preparation being developed for COVID-19 treatment. A Double-Blinded, Randomized, and Placebo-Controlled Phase 1 Study to Assess the Safety, Tolerability and Pharmacokinetics Profile of Single and Multiple Ascending Doses of FB2001 in Healthy Chinese Adults

Timeline

Start

2022-10-21

Primary completion

2022-12-30

Completion

2022-12-30

Drugs

Indications